Symphogen A/S
Elektrovej Building 375
DK-2800 Lyngby, Denmark
Telephone +45 4526 5050
Fax +45 4526 5060
info@symphogen.com

About Us

Products

Partnering

Technology

News Room

News

Symphogen appoints Ian Nicholson to Board of Directors

COPENHAGEN, Denmark  May 16, 2007. Symphogen A/S announced today that Ian Nicholson, B.Sc., MBA, has joined its Board of Directors. Mr. Nicholson is currently Chief Executive Officer of Chroma Therapeutics Limited and brings to Symphogen 25 years of experience in biotechnology business development, sales, and marketing.

Symphogen Granted New Allergy Patent

COPENHAGEN, Denmark  May 7, 2007. Symphogen A/S announced today that it has been granted European Patent number 1,283,720 B1 for use of polyclonal antibodies in allergy indications. The patent broadly covers the manufacture and use of allergen-specific polyclonal antibodies for the prevention and treatment of allergic reactions. Symphogen holds equivalent patents in the United States and India and has pending patent applications in additional countries.